Introduction - Gregory Piazza, MD, MS

Acute Coronary Syndromes in Women: A Gender-Focused Approach to Diagnosis and Treatment - Margo Minissian, PhD

When Heart Attacks Don’t Play by the Rules: The Challenge of Non-Atherosclerotic Coronary Disease - Malissa Wood, MD

An Enemy in Plain Sight: Thrombosis and Hypercoagulable States in Young Women - Gregory Piazza, MD, MS

Structural Heart Disease in Pregnant Women: Ensuring a Safe Pregnancy for Mother and Baby - Anne Marie Valente, MD

Understanding Why Stroke Presents a Disproportionate Cardiovascular Burden in Women - Kathryn Rexrode, MD

Panel Discussion: Answers to Commonly Asked Questions on Women's Cardivacular Health

-The following presenters/moderators:

Gregory Piazza, MD, MS
Kathryn Rexrode, MD, MPH
Anne Marie Valente, MD
Kathryn Mikkelsen, MBA (NATF Executive Director), moderator
Malissa Wood, MD
Margo B. Minissian, PhD, ACNP

By the end of the session the participant will be able to:

• List strategies for diagnosing and treating thrombophilia states in young women.
• Recall the risks associated with thrombophilia and cardiac conditions in pregnant women and formulate a strategy for treating patients with those conditions.
• Describe how stroke places a disproportionate cardiovascular burden onto women and formulate a strategy to prevent stroke.
• Identify the burden of nonatherosclerotic coronary disease in women.

ACCME Activity #201762751

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.

Margo B. Minissian, PhD, ACNP, NEABC, FAHA, FNLA, Research Scientist, Executive Director, Brawerman Institute, Nursing Education, Innovation, Performance Improvement Research Director, Postpartum Heart Health Program Smidt Heart Institute Cedars-Sinai Medical Center discloses consultant and medical advisory board compensation from Amgen.

Gregory Piazza, MD, MS, Associate Professor of Medicine, Harvard Medical School; Staff Physician, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, discloses grant/research support from BMS, Portola, BTG/EKOS, Janssen, Bayer, and Daiichi-Sankyo and is a consultant for Pfizer, Amgen, and Thrombolex.

Individuals with no conflicts of interest to disclose:

• Faculty member: Kathryn Rexrode, MD, MPH, Associate Professor, Harvard Medical School Chief, Division of Women's Health, Brigham and Women’s Hospital
• Faculty member: Anne Marie Valente, MD, Associate Professor of Medicine and Pediatrics, Harvard Medical School Section Chief, Boston Adult Congenital Heart (BACH) and Pulmonary Hypertension Program, Boston Children's Hospital, Brigham and Women's Hospital
• Faculty Member: Malissa J. Wood, MD, Associate Professor of Medicine, Harvard Medical School Co-director, Corrigan Women's Heart Health Program, Massachusetts General Hospital Heart Center
• Planning committee member and moderator: Kathryn Mikkelsen, MBA, NATF Executive Director, Brookline, MA
• Content reviewer: Charles J Turck, PharmD, BCPS, BCCCP, President, ScientiaCME

• Read the learning objectives above
• Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
• View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
• Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
• Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

*Required to view Printable PDF Version